Deoxyhypusine hydroxylase as a novel pharmacological target for ischemic stroke via inducing a unique post-translational hypusination modification.

MLA

Guo, Qiang, et al. “Deoxyhypusine Hydroxylase as a Novel Pharmacological Target for Ischemic Stroke via Inducing a Unique Post-Translational Hypusination Modification.” Pharmacological Research, vol. 176, Feb. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.phrs.2021.106046.

APA

Guo, Q., Zhang, Y.-C., Wang, W., Wang, Y.-Q., Liu, Y., Yang, Z., Zhao, M.-M., Feng, N., Wang, Y.-H., Zhang, X.-W., Yang, H., Liu, T.-T., Shi, L.-Y., Shi, X.-M., Liu, D., Tu, P.-F., & Zeng, K.-W. (2022). Deoxyhypusine hydroxylase as a novel pharmacological target for ischemic stroke via inducing a unique post-translational hypusination modification. Pharmacological Research, 176, N.PAG. https://doi.org/10.1016/j.phrs.2021.106046

Chicago

Guo, Qiang, Yi-Chi Zhang, Wei Wang, Yu-Qi Wang, Yang Liu, Zhuo Yang, Mei-Mei Zhao, et al. 2022. “Deoxyhypusine Hydroxylase as a Novel Pharmacological Target for Ischemic Stroke via Inducing a Unique Post-Translational Hypusination Modification.” Pharmacological Research 176 (February): N.PAG. doi:10.1016/j.phrs.2021.106046.